¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea : 2022-01-29

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea : 2022-01-29
±³À°ÀÏÀÚ : 2022-01-29
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ ÇѶó  
±³À°ÁÖÁ¦ : Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : ´ëÇÑÁ¾¾ç³»°úÇÐȸ
¿¬¶ôó : 02-735-2857  
À̸ÞÀÏ : meetings@ksmo.or.kr      
±³À°Á¾·ù : ³»°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú      
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 80,000¿ø      
ºñ°í »çÀüµî·Ï : Àü¹®ÀÇ 50000¿ø ÀüÀÓÀÇ 30000 ¿ø ±âŸ 70000¿ø ´çÀϵî·Ï : Àü¹®ÀÇ 60000¿ø ÀüÀÓÀÇ 40000 ¿ø ±âŸ 80000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01-29 ÇѶó 09:00~09:25 Discoveries in metastasis biology and tumor microenvironment  ÀÌ´ë¿ø(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 09:25~09:50 Immune landscape in breast cancer  ±è¹Îȯ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 09:50~10:15 Dynamic ctDNA and genomic profiles to monitor response prediction  ÀÌÁöÀº(°¡Å縯ÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 10:15~10:30 Q & A  () 
È޽Ġ01-29 ÇѶó 10:30~10:45 Coffee break  () 
±³À°½Ã°£ 01-29 ÇѶó 10:45~11:10 AI applied to imaging and biopsy  TBD(TBD) 
±³À°½Ã°£ 01-29 ÇѶó 11:10~11:35 Optimal loco-regional surgical management : Reducing the impact of axillary surgery  ¹Ú¼¼È£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 11:35~12:00 Updates in Radiotherapy : Should one week of RT be standard of care?  ÀåÁö¼®(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 12:00~12:25 Highlights of survivorship and lifestyle modification  °í¼öÁø(¿ï»êÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 12:25~12:40 Q & A  () 
±³À°½Ã°£ 01-29 ÇѶó 12:40~13:10 TBD  ÀÓ¼®¾Æ(¼­¿ïÀÇ´ë) 
È޽Ġ01-29 ÇѶó 13:10~13:30 Coffee break  () 
±³À°½Ã°£ 01-29 ÇѶó 13:30~13:55 Optimal adjuvant endocrine treatment for HR+/HER2- EBC  ±èÇÑÁ¶(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 13:55~14:20 Refining (neo)adjuvant immunotherapy and chemotherapy  ¹ÚÀÎÇý(°í·ÁÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 14:20~14:30 Q & A  () 
È޽Ġ01-29 ÇѶó 14:30~14:45 Coffee break  () 
±³À°½Ã°£ 01-29 ÇѶó 14:45~15:10 Advanced in systemic treatment options for HER2+ ABC  ½É¼ºÈÆ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 01-29 ÇѶó 15:10~15:35 Novel SERDs, CDK inhibitors and beyond in advanced HR+/HER- ABC  ±èÁöÇü(¿¬¼¼ÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 15:35~15:45 Q & A  () 
±³À°½Ã°£ 01-29 ÇѶó 15:45~16:10 Therapeutic advances and new directions for TNBC  ¹Ú°æÈ­(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 01-29 ÇѶó 16:10~16:35 New agents on the horizon  ÀÌ°æÀº(ÀÌÈ­ÀÇ´ë) 
Åä·Ð 01-29 ÇѶó 16:35~16:45 Q & A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of San Antonio Breast Cancer Symposium (SABCS) 2021 in Korea : 2022-01-29""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û °Ç°­º¸Çè ºòµ¥ÀÌÅÍ ÀÚ·áºÐ¼®À» ÅëÇÑ ³í¹®Ãâ°£ ¿öÅ©¼¥(2Â÷)(1ÀÏÂ÷) : 2022-02-04
´ÙÀ½±Û ´ëÇÑÇǺΰúÇÐȸ ºÎ»ê¿ï»ê°æ³² ÁöºÎȸ : 2022-01-28
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20670 ¼­¿ï 2024 ´ëÇѵðÁöÅÐÀÓ»óÀÇÇÐȸ ÇÏ°è Çмú´ëȸ : 2024-06-02 0 64 2024-05-10
20669 ¼­¿ï Á¦6ȸ ´ëÇѼö¼úÁ߽Űæ°è°¨½ÃÇÐȸ ¿¬¼ö°­Á : 2024-06-01 0 46 2024-05-10
20668 ºÎ»ê ±¸Á¶½ÉÁúȯ¿¬±¸È¸ The 7th K-SCI(Korea Structural Cardiovascular Intervention) Symposium : 2024-06-01 0 55 2024-05-10
20667 ±¤ÁÖ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ 2024³â ÇÁ·ÎÆ÷Æú ÁøÁ¤±³À° : 2024-06-01 0 45 2024-05-10
20666 ´ëÀü 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ ´ëÀü¼¼Á¾Áöȸ Ãá°èÇмú´ëȸ(°íÇ÷¾Ð, °ú¹Î¼º ÀåÁõÈıº, ¼ö¸éÀå¾Ö) : 2024-05-30 0 52 2024-05-10
20665 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø ºñ´¢ÀÇÇаú ¿¬¼ö°­Á : 2024-05-30 0 166 2024-05-10
20664 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø (¿Â¶óÀÎ)¼Ò¾Æû¼Ò³â°ú Çù·ÂÀÇ»ç Áý´ãȸ : 2024-05-28 0 47 2024-05-10
20663 ºÎ»ê ´ëÇѳ»°úÀÇ»çȸ Á¦1ȸ ÃÊÀ½ÆÄ ½ÇÀü ¾ÆÄ«µ¥¹Ì : 2024-05-27 0 86 2024-05-10
20662 ¼­¿ï ´ëÇѿ°èÁٱ⼼Æ÷Àç»ýÀÇÇÐȸ - Á¦20ȸ Ãá°èÇмú´ëȸ (ÇÏÀ̺긮µå) : 2024-05-26 0 49 2024-05-10
20661 ºÎ»ê ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ºÎ¿ï°æÁöȸ 5¿ù ¿¬¼ö°­Á : 2024-05-26 0 90 2024-05-10
20660 ¼­¿ï ´ëÇѽŰæ±Ù°ñ°áÃÊÀ½ÆÄÇÐȸ Á¦1ȸ ÇÚÁî¿Â ¿öÅ©¼ó : 2024-05-25 0 49 2024-05-10
20659 ´ëÀü ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-´ëÀüÃæ³² : 2024-05-25 0 56 2024-05-10
20658 ºÎ»ê ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦32Â÷ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-25 0 31 2024-05-10
20657 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø The 1st International Symposium on Precision Oncology in Breast Cancer : 2024-05-25 0 59 2024-05-10
20656 ¼­¿ï (¿Â¶óÀÎ)2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦1Â÷ FLS ÄÚµð³×ÀÌÅÍ ¿öÅ©¼ó : 2024-05-24 0 32 2024-05-10
31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷